Di Nunno V, Gatto L, Tosoni A, Bartolini S, et al. Letter concerning "Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between ORR and median overall survival": Toward surrogate endpoints for phase II trials in patients with recurrent gliobla Neuro Oncol 2023 May 12:noad071. doi: 10.1093.
PMID: 37171969